Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Annual Secretarial Compliance Report for the year ended 31st March, 2026
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Wockhardt Limited has filed its Annual Secretarial Compliance Report for the year ended 31st March 2026. The Practicing Company Secretary has certified that the company has prima facie complied with applicable SEBI regulations and has proper Board processes and compliance mechanisms in place. Two minor deviations were noted: (1) delay in disclosing the incorporation of three foreign step-down subsidiaries (Wockhardt Suisse AG, Wockhardt Suisse USA Holding Corp, and Wockhardt Suisse USA LLC) with disclosure made on 16th December 2025, and (2) delay in disclosing a GST Demand Order of Rs.90.23 Lakhs beyond the 24-hour timeline, with disclosure made on 31st December 2025. Both delays were attributed to inadvertent administrative oversight. Additionally, the report notes instances of insider trading code violations by designated persons where the company took appropriate actions. A prior year fine of Rs.10,000 each from NSE and BSE for a different matter has been paid.
Generally positive for shareholders as the company maintains proper compliance mechanisms. The minor delays and insider trading violations are administrative in nature with no fines imposed, suggesting low material risk. However, repeated disclosure delays warrant monitoring.